MENLO PARK, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Sight Sciences (SGHT), Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and ...

Glaucoma is often called the “silent thief of sight”, and for good reason. Millions live with this condition without even ...

Sight Sciences Inc. (NASDAQ:SGHT) on Tuesday announced that UnitedHealthcare has updated its Glaucoma Surgical Treatments policy to cover goniotomy, trabeculotomy, canaloplasty (ab interno), and ...

Open-angle glaucoma represents one of the most prevalent causes of irreversible sight loss globally. The principal aim of treatment is to lower intraocular pressure (IOP) to slow the progression of ...

Add Yahoo as a preferred source to see more of our stories on Google. It’s one of the most common causes of vision loss, and one of the easiest to overlook. Glaucoma symptoms develop so gradually that ...

Sight Sciences, Inc. has announced the launch of the OMNI® Edge Surgical System, an advanced technology designed for minimally invasive glaucoma surgery (MIGS). The new system will be showcased at the ...

Please provide your email address to receive an email when new articles are posted on . Decreases in mental health scores after glaucoma diagnosis may be associated with fears of vision loss or ...

Learn about causes of gradual and sudden-onset blurred vision, from eyestrain and refractive errors to cataracts and strokes, ...

MENLO PARK, Calif., May 06, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (SGHT) (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative technology that ...